ETF Managers Group’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-101,768
| Closed | -$397K | – | 642 |
|
|
2020
Q3 | $397K | Buy |
101,768
+7,915
| +8% | +$30.9K | 0.01% | 358 |
|
|
2020
Q2 | $367K | Buy |
+93,853
| New | +$367K | 0.01% | 320 |
|
|
2018
Q4 | – | Sell |
-33,152
| Closed | -$221K | – | 590 |
|
|
2018
Q3 | $221K | Buy |
+33,152
| New | +$221K | 0.01% | 242 |
|
|
2017
Q3 | – | Sell |
-8,981
| Closed | -$73K | – | 490 |
|
|
2017
Q2 | $73K | Buy |
+8,981
| New | +$73K | 0.01% | 210 |
|